If you’re seeking insights into Eli Lilly Stock Forecast for 2025, 2030, 2040 and analyze, Is LLY a buy sell or hold?
Our Eli Lilly stock price analysis relies on thorough technical and fundamental research and past 10 years stock performance. In this analysis, we aim to assess the long-term potential of Eli Lilly’s stock.
| OPEN | $520.37 |
| DAY RANGE | $516.89 – $532.53 |
| 52 WEEK RANGE | $296.32 – $538.00 |
| MARKET CAP | $495.14B |
| SHARES OUTSTANDING | 949.3M |
| PUBLIC FLOAT | 846.28M |
| BETA | 0.62 |
| REV. PER EMPLOYEE | $756.81K |
| P/E RATIO | 74.25 |
| EPS | $7.09 |
| YIELD | 0.86% |
| DIVIDEND | $1.13 |
| EX-DIVIDEND DATE | Aug 14, 2023 |
| SHORT INTEREST | 4.78M 07/31/23 |
| % OF FLOAT SHORTED | 0.57% |
| AVERAGE VOLUME | 2.86M |
Table of Contents
Let Us Blossom with these Rising Stocks: AWLIF Stock Forecast Blissful Growth Potential of 2023 | Black Rifle Coffee Stock Price: Is BRCC Forecast 2025 a Buy? | How To Buy Dogecoin on eToro for just $10 in 3 easy steps.
Eli Lilly and Co. (LLY) History
Established in 1876 by Colonel Eli Lilly, the company’s (Eli Lilly and Co.) HISTORY are rooted in the pursuit of crafting reliable medicines, contrasting the questionable elixirs sold by dubious figures at the time. Colonel Lilly’s directive to successive generations of employees has been unwavering: “Enhance and improve upon what you encounter here.”
Over 145 years have passed, yet the company’s fidelity to his vision persists in every facet of their operations, encompassing those who benefit from their medicines, healthcare professionals, staff, and the local communities they engage with.
The company produces several well-known pharmaceutical products, including:
- Prozac (Fluoxetine) for managing depression and mental health conditions.
- Cialis (Tadalafil) used to treat erectile dysfunction.
- Cymbalta (Duloxetine) for addressing anxiety disorders.
- Humalog (Insulin lispro) to regulate blood sugar levels.
- Alimta (Pemetrexed) for the treatment of specific cancer types.
- Trulicity (Dulaglutide) to enhance glycemic control for type 2 diabetes.
| Lilly and Co. 12-Month PERFORMANCE | |
| 5 Day | 17.16% |
| 1 Month | 21.06% |
| 3 Month | 20.82% |
| YTD | 43.84% |
| 1 Year | 74.73% |
eli lilly and company financial statements:
The company’s financial performance over the past five years has been noteworthy:
| Year | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenue | $22.3B | $24.5B | $28.3B | $28.5B |
| Net Income | $4.64B | $6.19B | $5.58B | $6.24B |
| EPS (Diluted) | 4.96 | 6.79 | 6.12 | 6.9 |
Factors that impact Future Performance of Eli Lilli Stock
Development of new products: The company’s growth hinges on the success of its research and development efforts for new products.
Financial Performance: How well the company’s revenue, earnings, and profitability grow or decline will directly affect LLY stock.
Competition: Eli Lilly holds competitive advantages over its rivals, which could drive substantial growth.
Pharma Sector Performance: LLY stock’s performance may vary according to the broader trends in the pharmaceutical sector.
Eli Lilly Stock Forecast | Eli Lilly Price Prediction
According to our fundamental analysis for Eli Lilly Stock Forecast (LLY) have a median price target of $598.50, with a high estimate of $664.65 and a low estimate of $327.60. The average estimate represents a -0.89% from current price of 526.70.
Eli Lilly Stock Forecast 2025
| Year | Average Price | Maximum Price | Minimum Price |
|---|---|---|---|
| 2025 | $708.51 | $745.80 | $569.76 |
LLY stock price has been going up steadily, and experts believe it will continue to do well. According to our Fundamental analysis, Eli Lilly stock price could reach $569.76 to $745.80 by the end of Dec. 2025. The average price will be 708.51 by end of Dec. 2025.
Eli Lilly Stock Forecast 2030
| Year | Average Price | Maximum Price | Minimum Price |
|---|---|---|---|
| 2030 | $1390 | $1630 | $1150 |
The company might experience significant business growth in the future. Experts predict that by 2030, the company’s revenue could increase by as much as 95%.
Regarding Eli Lilly’s stock price prediction for 2030, despite the long upward trend, there could also be a period of bearish trading.
According to our analysis, in the year 2030, the average price of the stock can be up to $1390, and the maximum price can be up to $1630. By the way minimum price can fall up-to $1150 and, observing the stock’s performance over the past 5 years, it appears that the stock’s price target might be higher than what our analysis currently indicates.
Eli Lilly Stock Forecast 2040
| Year | Average Price | Maximum Price | Minimum Price |
|---|---|---|---|
| 2040 | $4161 | $4972 | $3348 |
Discussing Eli Lilly’s long-term price prediction, there are promising growth possibilities for the company’s business ahead, which could lead to notable stock price growth.
Regarding Eli Lilly’s stock price prediction for 2040, taking into account the company’s rising revenue and the stock’s performance over the past decade, it’s reasonable to expect the stock to trade at a higher price in 2040.
The average price of Eli Lilly stock can reach $4161 and the maximum price can reach $4972 and LLY Price may go down in bearish condition to $3348 in 2030 If the stock does not split.
What is Eli Lilly Stock Price Prediction.
Eli Lilly stock price prediction 2025: The average Eli Lilly stock price is predicted to be around $708.51, with a potential high of $745.80 and a low of $569.76.
Looking ahead to Eli Lilly stock price prediction 2030: The average price for Eli Lilly stock could reach about $1390, with a potential maximum of $1630 and a minimum of $1150.
For the long-term Eli Lilly stock price prediction 2040: The analysts suggests an average Eli Lilly stock price of approximately $4161. The price might peak at around $4972 and possibly dip to a low of $3348.
can eli lilly stock reach $1000?
For Lilly (Eli) & Co stock to reach $1000, it needs to go up by 91.39%. The company’s future looks promising, with a potential revenue boost of around 93.01% by 2030. This suggests Eli Lilly stock can reach $1000 by 2030.
The stock has been going up, and experts still feel positive about LLY stock price Forecast in 2030.
Disclaimer: The information presented in this article (ELI LILLY STOCK FORECAST)is intended for informational purposes only and should not be construed as investment advice. It is advisable to conduct comprehensive research and implement proper risk management strategies before making any investment choices.
FAQ – Eli Lilly Stock Forecast.
-
Is Eli Lilly a buy sell or hold?
Eli Lilly and stock has received a consensus rating of buy. The average rating score is and is based on 72 buy ratings, 12 hold ratings, and 0 sell ratings.
-
Are Eli Lilly a overvalued stock?
Yes, Eli Lilly & Co.’s price is significantly overvalued due to signs of market over-optimism.
-
What is Eli Lilly Price Today?
Real-Time: current stock price of eli lilly (NYSE: LLY) Today is 525.86 USD −0.36 (0.069%)
-
why did lilly stock go up today?
Eli Lilly’s stock saw an upward climb on Thursday, driven by an upgrade from Jefferies analyst. This upgrade followed robust sales of the company’s diabetes drug.
-
Will eli lilly stock split in 2023?
As reported by PRNewswire, the board of directors of Eli Lilly and Company (NYSE: LLY) has announced a dividend for the second quarter of 2023.
-
How high will Eli Lilly stock go?
Eli Lilly is growing rapidly and it can be a multi-trillionaire company in the next 10 years. Based on the Eli Lilly long-term forecast, LLY stock can go up to $745.80 in 2025, $1630 in 2030, and $4972 before the end of 2040.
